Rekombinanter FDFT1 Antikörper
Kurzübersicht für Rekombinanter FDFT1 Antikörper (ABIN7127486)
Target
Alle FDFT1 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human FDFT1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- FDFT1 (Farnesyl-Diphosphate Farnesyltransferase 1 (FDFT1))
-
Andere Bezeichnung
- FDFT1
-
Hintergrund
-
Background: endoplasmic reticulum, endoplasmic reticulum membrane, integral component of membrane, farnesyl-diphosphate farnesyltransferase activity, squalene synthase activity, cholesterol biosynthetic process, farnesyl diphosphate metabolic process, regulation of cholesterol biosynthetic process, regulation of lipid metabolic process, steroid biosynthetic process
Aliases: Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase), FDFT1
-
UniProt
- P37268
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-